These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11020773)

  • 21. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
    Aydogan F; Celik V; Uras C; Salihoglu Z; Topuz U
    Am J Surg; 2008 Feb; 195(2):277-8. PubMed ID: 18194680
    [No Abstract]   [Full Text] [Related]  

  • 22. Blue dye of choice for lymphatic mapping.
    Vargas HI
    J Clin Oncol; 2005 May; 23(15):3648; author reply 3648-9. PubMed ID: 15908691
    [No Abstract]   [Full Text] [Related]  

  • 23. A cautionary tale: anaphylaxis to isosulfan blue dye after 12 years and 3339 cases of lymphatic mapping.
    Kaufman G; Guth AA; Pachter HL; Roses DF
    Am Surg; 2008 Feb; 74(2):152-5. PubMed ID: 18306869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patent blue dye and an atypical anaphylactic reaction after sentinel lymph node biopsy in early breast cancer.
    Dang Y; Engel J
    Breast J; 2012; 18(1):91-2. PubMed ID: 22097970
    [No Abstract]   [Full Text] [Related]  

  • 25. 10 % fluorescein sodium vs 1 % isosulfan blue in breast sentinel lymph node biopsy.
    Ren L; Liu Z; Liang M; Wang L; Song X; Wang S
    World J Surg Oncol; 2016 Nov; 14(1):280. PubMed ID: 27809854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anaphylactic shock after injection of patent blue for sentinel lymph node biopsy].
    de Vries J
    Ned Tijdschr Geneeskd; 2002 Jan; 146(1):46-7. PubMed ID: 11802338
    [No Abstract]   [Full Text] [Related]  

  • 27. Feeling blue, going green and finding other attractive alternatives: a case of biphasic anaphylaxis to patent blue and a literature review of alternative sentinel node localisation methods.
    Iqbal FM; Basit A; Salem F; Vidya R
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26670899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Patent blue V : inert dye or potent allergen].
    Rogler V; Röhm C; Reutershan J
    Anaesthesist; 2010 May; 59(5):423-6. PubMed ID: 20224949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factious desaturation due to isosulfan dye injection.
    Rizzi RR; Thomas K; Pilnik S
    Anesthesiology; 2000 Oct; 93(4):1146-7. PubMed ID: 11020774
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of an anaphylactic reaction to an old substance--patent blue--for a new indication.
    Bouman EA; Songun I; Marcus MA
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1066. PubMed ID: 15315629
    [No Abstract]   [Full Text] [Related]  

  • 31. Staining of endotracheal tube with isosulfan blue dye after sentinel node mapping: a case report.
    Wear KD; Karsif K; Turner J
    Breast J; 2003; 9(1):47-8. PubMed ID: 12558672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaphylactic response to blue dye during sentinel lymph node biopsy.
    Bézu C; Coutant C; Salengro A; Daraï E; Rouzier R; Uzan S
    Surg Oncol; 2011 Mar; 20(1):e55-9. PubMed ID: 21074413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allergy to Blue Dye.
    Martín-Lázaro J; Núñez-Orjales R; Battikhi-Precedo N; López-Freire S; Carballada-González F
    J Investig Allergol Clin Immunol; 2016; 26(6):381-383. PubMed ID: 27996948
    [No Abstract]   [Full Text] [Related]  

  • 34. Anaphylaxis to isosulfan blue.
    Laurie SA; Khan DA; Gruchalla RS; Peters G
    Ann Allergy Asthma Immunol; 2002 Jan; 88(1):64-6. PubMed ID: 11814281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug reactions during lymphatic mapping and sentinel lymph node biopsy for solid neoplasms.
    Amr D; Broderick-Villa G; Haigh PI; Guenther JM; DiFronzo LA
    Am Surg; 2005 Sep; 71(9):720-4. PubMed ID: 16468505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Case of Anaphylaxis to Patent Blue in a Patient with Sentinel Lymph Node Excision.
    Aurich S; Seitz AT; Tomm J; Simon JC; Treudler R
    Iran J Allergy Asthma Immunol; 2016 Dec; 15(6):547-550. PubMed ID: 28129687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaphylactic reaction to isosulphan blue.
    Stefanutto TB; Shapiro WA; Wright PM
    Br J Anaesth; 2002 Sep; 89(3):527-8. PubMed ID: 12402742
    [No Abstract]   [Full Text] [Related]  

  • 38. Type I sensitization towards patent blue as a cause of anaphylaxis.
    Forschner K; Kleine-Tebbe A; Zuberbier T; Worm M
    Allergy; 2003 May; 58(5):457-8. PubMed ID: 12752342
    [No Abstract]   [Full Text] [Related]  

  • 39. Anaphylaxis to patent blue dye during sentinel lymph node biopsy for breast cancer.
    Mullan MH; Deacock SJ; Quiney NF; Kissin MW
    Eur J Surg Oncol; 2001 Mar; 27(2):218-9. PubMed ID: 11289765
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes.
    Scherer K; Studer W; Figueiredo V; Bircher AJ
    Ann Allergy Asthma Immunol; 2006 Mar; 96(3):497-500. PubMed ID: 16597088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.